In its response, the PMO on October 23 said, “The grievance submitted by the applicant is regarding the violation of Rule 106A (C) of Drug Rules, 1945 w.r.t. Insulin Tablets, Homeopathic proprietary medicine. In this regard, the matter has already been communicated to the Drugs Controller (Rajasthan), and a response has been received. It has stated that the manufacturing licencee has not submitted the application for the renewal of the licence for the said product. Hence, the licence for the said product is cancelled.”An elated Dr Babu said, “My concern was that a tablet with the name insulin is available in the market, which may confuse the public, and they may switch from insulin injection to tablets. This would cause major health issues, especially among kids.Inaction by authoritiesDespite directions from DCGI and the ayush ministry to Rajasthan authorities to take action against the company for violating the Drugs and Cosmetics Act of 1940, no action was taken. Insulin is a medication used in management of diabetes mellitus type-1 and sometimes type-2, both of which are significant risk factors to coronary artery disease, stroke.
Source link
